Squarepoint Ops LLC Biogen Inc. Call Options Transaction History

Squarepoint Ops LLC

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$189.07 - $236.8 $207,977 - $260,480	1,100 New	1,100 $213,000
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $445,242 - $562,191	2,100 Added 36.84%	7,800 $1.68 Million
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $1.27 Million - $1.53 Million	5,700 New	5,700 $1.47 Million
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $16.3 Million - $18.5 Million	-63,400 Reduced 96.65%	2,200 $611,000
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $16.6 Million - $20.1 Million	65,600 New	65,600 $18.2 Million
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $131,278 - $156,114	700 Added 14.89%	5,400 $1.1 Million
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $33.5 Million - $42.2 Million	-172,700 Reduced 97.35%	4,700 $990,000
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $2.46 Million - $3.17 Million	-11,000 Reduced 5.84%	177,400 $42.6 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $1.53 Million - $1.99 Million	5,400 Added 2.95%	188,400 $53.3 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $43.5 Million - $69.6 Million	167,800 Added 1103.95%	183,000 $63.4 Million
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $3.69 Million - $4.33 Million	15,200 New	15,200 $4.25 Million

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.